What Clinical Parameters And Epidermic Cooling Protocols Are Recommended When Operating Vascular-Targeted Lasers To Treat Erythematous Hypertrophic Burn Scars? Optimize Safety And Efficacy

For erythematous hypertrophic burn scars, a commonly cited vascular-laser protocol uses a 585 nm pulsed-dye laser with a 300 microsecond pulse duration, 5 mm spot size, 6–8 J/cm² fluence, and 10–20% spot overlap. Continuous epidermal cooling, such as dynamic contact cooling, cryogen spray, or forced cold air, should be used throughout treatment to protect the epidermis, reduce pain, and limit purpura, crusting, and blistering. Treatment is generally repeated over 3–5 sessions at 6–8 week intervals, although dense or fibrotic scars may require additional sessions.

The practical objective is selective vascular injury while preserving the epidermis. Laser fluence, spot size, pulse duration, overlap, and cooling must be adjusted to the scar’s vascularity, thickness, location, and the patient’s skin phototype, with the immediate tissue response guiding subsequent treatments.

Selecting the Clinical Laser Parameters

Use a vascular-targeted wavelength

The primary reference protocol is based on a 585 nm pulsed-dye laser, which targets hemoglobin within the abnormal microvasculature of erythematous hypertrophic scars.

Selective yellow or green vascular lasers may also be used, but the device-specific wavelength, pulse structure, and cooling requirements must be validated by the treating clinician.

Start with conservative fluence

A typical starting range is 6–8 J/cm² with a 5 mm spot size and approximately 300 microseconds pulse duration.

Supplementary protocols describe approximately 6.0–7.5 J/cm² for 5–7 mm spots. Larger 10 mm spots may require lower fluences, commonly around 4.5–5.5 J/cm², because the treated area and delivered energy distribution differ.

Control pulse overlap

For the primary 585 nm protocol, use approximately 10–20% spot overlap to achieve consistent coverage across the scar.

Some protocols instead recommend adjacent, non-overlapping pulses. This difference reflects variation among devices and treatment objectives; the operator should follow the validated protocol for the specific laser system rather than combining settings from different platforms.

Adjust for skin phototype

For darker skin phototypes, an initial fluence reduction of approximately 10% can reduce the risk of epidermal thermal injury and post-inflammatory hyperpigmentation.

Fluence may be increased by about 10% in later sessions when the response is inadequate and the epidermis remains clinically unaffected. This adjustment should be made cautiously and only after evaluating the treatment response.

Protecting the Epidermis During Treatment

Use active cooling during laser delivery

Continuous or synchronized epidermal cooling is essential, particularly when treating intensely erythematous or highly vascular scars.

Acceptable modalities include:

Dynamic cooling devices or cryogen spray
Forced cold-air cooling
Sapphire or other contact-cooling systems
Cold packs after treatment for transient burning

Cooling limits heat conduction from the targeted dermal vessels into the superficial epidermis. It also reduces procedural discomfort and can permit effective vascular treatment with less risk of blistering or crusting.

Coordinate cooling with laser emission

One example of synchronized dynamic cooling is a 30 ms cryogen pulse with a 20 ms delay before laser emission, commonly described as a 30:20 DCD setting.

Device timing is platform-specific. The clinician must confirm that the cooling pulse, delay, and laser emission are appropriate for the selected wavelength, pulse duration, spot size, and target depth.

Match cooling to target depth

Superficial vascular targets generally require shorter cooling exposure, while thicker scars or deeper vascular structures may require longer or more sustained cooling to maintain epidermal protection.

Cooling should protect the epidermis without removing so much heat that the intended dermal vessels fail to reach the therapeutic temperature. This balance is particularly important when treating thick, fibrotic, or densely vascular scars.

Using Clinical Endpoints Safely

Assess the immediate vascular response

For vascular pulsed-dye treatment, purpura is commonly used as a clinical endpoint indicating effective vessel coagulation.

However, purpura should be distinguished from excessive injury. Increasing pain, blistering, marked whitening, epidermal disruption, or immediate oozing suggests that the delivered energy or thermal exposure may be excessive.

Respond to adverse tissue reactions

If treatment produces crusting, blistering, or oozing, the fluence should be reduced and the cooling strategy reassessed before another session.

Expected short-term reactions may include erythema and edema. Hyperpigmentation, scabbing, blistering, and persistent epidermal injury require closer clinical evaluation and may indicate excessive thermal exposure.

Do not substitute endpoints between laser types

Ash-white blanching is described in pigment-targeting protocols, particularly for hyperpigmented scars treated with pigment-selective wavelengths such as 510 or 532 nm systems.

That endpoint should not automatically be applied to a vascular-only protocol for erythematous scars. The selected laser’s wavelength and chromophore target determine the appropriate endpoint.

Scheduling and Treatment Course

Plan repeated sessions

A typical course consists of 3–5 treatments spaced 6–8 weeks apart.

This interval allows acute erythema, edema, purpura, and other tissue reactions to resolve before the next assessment and permits gradual modification of fluence or cooling.

Expect variation by scar density

Dense, thick, or fibrotic scars may require up to 8 sessions.

The number of treatments should be based on objective changes in erythema, pliability, thickness, symptoms, and function rather than on a predetermined number alone. The primary reference reports that substantial improvement may occur over the treatment course, but individual outcomes vary.

Understanding the Trade-offs

Higher fluence may improve clearance but increase injury risk

Higher fluence can increase vascular lesion clearance, but it also raises the risk of epidermal burns, blistering, crusting, and post-inflammatory pigment alteration.

Cooling reduces this risk but does not eliminate it. It should not be used to justify indiscriminate increases in energy.

Spot size changes the appropriate fluence

A fluence appropriate for a 5–7 mm spot should not be transferred directly to a 10–12 mm spot.

Larger spots may require lower fluence, while device architecture, pulse profile, repetition rate, and cooling performance also affect the actual tissue response.

Skin phototype affects risk

Darker skin contains more epidermal melanin, which can absorb laser energy and increase the risk of thermal injury or post-inflammatory hyperpigmentation.

A lower starting fluence, effective cooling, conservative test spots, and careful follow-up are therefore particularly important.

Ocular protection is mandatory near the orbit

When treating scars or vascular lesions near the eye, appropriate ocular protection is required.

For procedures involving the orbit, internal corneal shields may be necessary to prevent retinal or intraocular laser injury. This is a specialist procedural requirement, not an optional comfort measure.

Applying the Protocol in Practice

The following recommendations summarize how to adapt the protocol to the primary treatment goal:

If your primary focus is erythema reduction: Begin with a validated 585 nm vascular-laser protocol near 6–8 J/cm², using a 300 microsecond pulse, 5 mm spot, and 10–20% overlap where appropriate.
If your primary focus is epidermal safety: Use active cooling throughout laser delivery, consider an approximately 10% lower starting fluence for darker phototypes, and reduce energy if blistering, crusting, or oozing occurs.
If your primary focus is treatment optimization: Reassess the scar after each 6–8 week interval and adjust fluence gradually according to the vascular endpoint and epidermal response.
If your primary focus is a thick or fibrotic scar: Anticipate more sessions, potentially up to eight, while monitoring changes in bulk, pliability, symptoms, and function.
If your primary focus is treatment near the eye: Use rigorous wavelength-appropriate ocular protection and refer to a clinician experienced in periocular laser procedures.

Safe treatment depends on achieving selective vascular coagulation while maintaining an intact, clinically protected epidermis.

Summary Table:

Parameter	Recommended Range	Considerations
Wavelength	585 nm (PDL)	Selective for hemoglobin; others validated by clinician
Pulse duration	~300 μs	Short to target vessels
Spot size	5–7 mm	Larger spots require lower fluence
Fluence	6–8 J/cm² (5 mm)	Start lower (10% reduction) for darker skin
Overlap	10–20%	Avoid excessive overlap to prevent injury
Cooling	Continuous dynamic cooling	e.g., cryogen spray (30 ms, 20 ms delay)
Sessions	3–5 (up to 8 for dense scars)	Spaced 6–8 weeks apart

Ready to elevate your clinic's vascular laser treatments? BELIS offers state-of-the-art aesthetic devices, including PDL and other vascular lasers, designed for safety and efficacy. Partner with us to access advanced technology, training, and support. Contact us today to discuss how our solutions can enhance patient outcomes and grow your practice.